Atlas Trials

Hematopoietic Cell Transplantation Recipient

19 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Hematopoietic Cell Transplantation Recipient

RecordFirmDate
Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies (NCT03272633)Rutgers, The State University of New Jersey2020-10-26
Human Lysozyme Goat Milk in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant (NCT03531281)City of Hope Medical Center2018-12-30
Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Reducing CMV Related Complications in Patients With Blood Cancer Undergoing Donor Stem Cell Transplant (NCT03438344)City of Hope Medical Center2018-12-01
Venetoclax, Carmustine, Etoposide, Cytarabine, and Melphalan Before Stem Cell Transplant in Treating Participants With Relapsed or Refractory Non-Hodgkin Lymphoma (NCT03583424)Ohio State University Comprehensive Cancer Center2018-09-10
Study of Personalized Melphalan Dosing in the Setting of Autologous Transplant (NCT03328936)Ohio State University Comprehensive Cancer Center2018-09-01
SmART Heart: Study of mHealth Apps to Reduce Cancer-Treatment Effects on the Heart (NCT03574012)Fred Hutchinson Cancer Center2018-08-31
Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic Syndrome (NCT03494569)City of Hope Medical Center2018-07-06
Positive Psychology Intervention to Improve Quality of Life in Stem Cell Transplant Survivors and Their Caregivers (NCT03525106)Fred Hutchinson Cancer Center2018-05-18
Ibrutinib in Preventing Acute Leukemia in Patients After Reduced-Intensity Conditioning and Stem Cell Transplant (NCT03267186)Andrew Rezvani2017-09-12
Gluten Free Diet in Preventing Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplant (NCT03102060)Rutgers, The State University of New Jersey2017-08-22
Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia (NCT03195010)Fred Hutchinson Cancer Center2017-06-09
High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant (NCT02860039)Vanderbilt-Ingram Cancer Center2016-09-01
Eltrombopag Olamine in Increasing Platelet Counts in Patients Undergoing Transplant (NCT01927731)M.D. Anderson Cancer Center2013-10-14
Ixazomib Citrate and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma (NCT01718743)M.D. Anderson Cancer Center2012-12-03
Gemcitabine Hydrochloride, Clofarabine, and Busulfan Before Donor Stem Cell Transplant in Treating Patients With Refractory B-Cell or T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma (NCT01701986)M.D. Anderson Cancer Center2012-10-25
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies (NCT00736749)Children's Oncology Group2008-07-17
Bone Marrow Transplantation Using CD34-Selected Stem Cells From Related or Unrelated Donors in Treating Participants With Cancer or Other Disorders (NCT03626285)OHSU Knight Cancer Institute

Track Hematopoietic Cell Transplantation Recipient automatically

Every clearance here is in the API, with alerts when new ones post.